These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1887 related articles for article (PubMed ID: 14737169)

  • 1. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
    Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding a way out: lymphocyte egress from lymphoid organs.
    Schwab SR; Cyster JG
    Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
    Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
    Hofmann M; Brinkmann V; Zerwes HG
    Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
    Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC; Bode C; Gräler MH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
    Gräler MH; Goetzl EJ
    FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kruppel-like factor 2 regulates thymocyte and T-cell migration.
    Carlson CM; Endrizzi BT; Wu J; Ding X; Weinreich MA; Walsh ER; Wani MA; Lingrel JB; Hogquist KA; Jameson SC
    Nature; 2006 Jul; 442(7100):299-302. PubMed ID: 16855590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
    Cyster JG
    Annu Rev Immunol; 2005; 23():127-59. PubMed ID: 15771568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
    J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H; Zimmermann K; Kleuser B
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
    Alfonso C; McHeyzer-Williams MG; Rosen H
    Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
    Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
    J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.